Log in to your Inderes Free account to see all free content on this page.

OMDA

Less than 1K followers

OMDA

Euronext Growth Oslo

Software

Technology

Overview

Ownership

Investor consensus

OMDA operates in the technology industry. The company specializes in the development of digital platforms for healthcare. The software is self-developed and is mainly used for analysis and monitoring of various areas within healthcare. In addition to the main business, various value-added services are also offered. Operations are held on a global level with the largest presence in the European market.

Market cap

-

Turnover

-

Revenue

EBIT %

P/E

Dividend yield-%

All

Press releases

ShowingAll content types

Regulatory press release11/14/2025, 6:00 AM

OMDA: Omda reports 30% EBITDA margin in Q3 2025

Regulatory press release11/12/2025, 10:55 AM

OMDA: Invitation to presentation of Omda's Q3 results

Regulatory press release9/25/2025, 3:53 PM

OMDA AS - SIMPLIFIED STOCK EXCHANGE ANNOUNCEMENT

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release9/23/2025, 1:29 PM

OMDA AS - MERGER NOTIFICATION

Regulatory press release9/16/2025, 5:19 PM

OMDA AS - Mandatory notification of trade by primary insiders

Regulatory press release9/11/2025, 3:44 PM

OMDA AS - Mandatory notification of trade by primary insiders

Regulatory press release9/1/2025, 2:34 PM

OMDA AS - Mandatory notification of trade by primary insiders

Regulatory press release8/29/2025, 5:00 AM

OMDA: Omda delivers 16% revenue growth and doubles EBITDA

Regulatory press release8/27/2025, 6:00 AM

OMDA: Invitation to presentation of Omda's Q2 results

Regulatory press release5/14/2025, 5:00 AM

OMDA: Omda delivers 15% growth and 22% EBITDA margin

Regulatory press release5/13/2025, 7:59 AM

OMDA: Invitation to presentation of Omda's Q1-25 results

Regulatory press release4/25/2025, 11:22 AM

Omda AS: Minutes from the annual general meeting

Regulatory press release4/22/2025, 10:34 AM

OMDA: Omda wins long term contract with Karolinska University Hospital

Regulatory press release4/11/2025, 8:52 AM

Omda AS - Notice of Annual General Meeting

Regulatory press release4/11/2025, 6:12 AM

OMDA: Omda delivered steadily increasing recurring revenues in 2024

Regulatory press release3/21/2025, 6:49 PM

OMDA AS - Mandatory notification of trade by primary insiders

Regulatory press release3/19/2025, 6:30 PM

OMDA AS - Mandatory notification of trade by primary insiders

Regulatory press release3/13/2025, 7:03 PM

OMDA AS - Mandatory notification of trade by primary insiders

Regulatory press release3/12/2025, 12:50 PM

OMDA AS - Mandatory notification of trade by primary insiders

Regulatory press release3/7/2025, 6:51 PM

OMDA AS - Mandatory notification of trade by primary insiders

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.